NeuroOne Secures First Pharmaceutical Industry Order for Drug Delivery Platform

Bitget2026/10/22 12:33

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

NeuroOne secured its first pharmaceutical industry purchase order for StereoCED to support a Tier 1 global pharmaceutical company's preclinical research program.
The large-animal study is expected to begin early next year, using the platform's targeted brain drug delivery and neurological monitoring capabilities.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuroone Medical Technologies Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610220831PRIMZONEFULLFEED9851162) on October 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

NeuroOne Secures First Pharmaceutical Industry Order for Drug Delivery Platform

You may also like

Crypto prices